These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69. Human amnion epithelial cells and their soluble factors reduce liver fibrosis in murine non-alcoholic steatohepatitis. Kuk N; Hodge A; Sun Y; Correia J; Alhomrani M; Samuel C; Moore G; Lim R; Sievert W J Gastroenterol Hepatol; 2019 Aug; 34(8):1441-1449. PubMed ID: 30821873 [TBL] [Abstract][Full Text] [Related]
70. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis. Sugino H; Kumagai N; Watanabe S; Toda K; Takeuchi O; Tsunematsu S; Morinaga S; Tsuchimoto K J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963 [TBL] [Abstract][Full Text] [Related]
71. Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats. Hayashizaki-Someya Y; Kurosaki E; Takasu T; Mitori H; Yamazaki S; Koide K; Takakura S Eur J Pharmacol; 2015 May; 754():19-24. PubMed ID: 25701721 [TBL] [Abstract][Full Text] [Related]
72. Genistein alleviates the development of nonalcoholic steatohepatitis in ApoE(-/-) mice fed a high-fat diet. Jeon S; Park YJ; Kwon YH Mol Nutr Food Res; 2014 Apr; 58(4):830-41. PubMed ID: 24214843 [TBL] [Abstract][Full Text] [Related]
73. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174 [TBL] [Abstract][Full Text] [Related]